1. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fbrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000;161:5–8.
2. Park J, Kim DS, Shim TS, et al. Lung cancer in patients with idiopathic pulmonary fbrosis. Eur Respir J. 2001;17:1216–9.
3. Sato T, Watanabe A, Kondo H, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung disease. J Thorac Cardiovasc Surg. 2015;149:64–9.
4. Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2011. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2013;61:578–607.
5. Watanabe A, Miyajima M, Mishina T, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fbrosis. Gen Thorac Cardiovasc Surg. 2013;61:254–61.
6. Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cadiovasc Surg. 2014;147:1604–11.
7. Fei F, Qu J, Li C, Wang X, Li Y, Zhang S. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci. 2017. https://doi.org/10.1186/s13578-017-0191-1.
8. Zhang W, Ohno S, Steer B, et al. S100a4 is secreted by alternatively activated alveolar macrophages and promotes activation of lung fbroblasts in pulmonary fbrosis. Front Immunol. 2018. https://doi.org/10.3389/ fmmu.2018.01216.
9. Li Y, Bao J, Bian Y, et al. S100A4+ macrophages are necessary for pulmonary fbrosis by activating lung fbroblasts. Front Immunol. 2018. https:// doi.org/10.3389/fmmu.2018.01776.
10. Akiyama N, Hozumi H, Isayama T, et al. Clinical signifcance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fbrosis. Respirology. 2020;25:743–9.
11. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classifcation for lung cancer. J Thorac Oncol. 2016;11:39–51.
12. Raghu G, Collard HR, Egan JJ, et al. An ofcial ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fbrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.
13. Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Hybrid surgical approach of video-assisted minithoracotomy for lung cancer: signifcance of direct visualization on quality of surgery. Chest. 2005;128:2696–701.
14. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classifcation of surgical complications; fve-year experience. Ann Surg. 2009;250:187–96.
15. Ohsawa M, Tsutani Y, Fujiwara M, Mimae T, Miyata Y, Okada M. Predicting severe postoperative complication in patients with lung cancer and interstitial pneumonia. Ann Thorac Surg. 2020;109:1054–60.
16. Sato T, Kondo H, Watanabe A, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164–72.
17. Tsutani Y, Mimura T, Kai Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089–96.
18. Oh SY, Kim MY, Kim JE, et al. Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia: serial CT features. Am J Roentgenol. 2015;204:1190–6.
19. Xia H, Bodempudi V, Benyumov A, et al. Identifcation of a cell-of-origin for fbroblasts comprising the fbrotic reticulum in idiopathic pulmonary fbrosis. Am J Pathol. 2014;184:1369–83.
20. Xia H, Gilbertsen A, Herrera J, et al. Calcium-binding protein S100A4 confers mesenchymal progenitor cell fbrogenicity in idiopathic pulmonary fbrosis. J Clin Invest. 2017;12:2586–97.
21. Li Z, Li Y, Liu S, Qin Z. Extracellular S100A4 as a key player in fbrotic diseases. J Cell Mol Med. 2020;24:5973–83.
22. Zhang H, Liu J, Yue D, et al. Clinical signifcance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma. J Clin Pathol. 2013;66:937–45.
23. Miyazaki N, Abe Y, Oida Y, et al. Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression. Int J Oncol. 2006;28:1369–74.
24. Sack U, Walther W, Scudiero D, et al. Novel efect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst. 2011;103:1018–36.
25. Cadamuro M, Spagnuolo G, Sambado L, et al. Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma. Cancer Res. 2016;76:4775–84.
26. Tanaka K, Tsutani Y, Wakabayashi M, et al. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fbrosis: a phase III study evaluating survival (JCOG1708, SURPRISE). Jpn J Clin Oncol. 2020;50:1076–9.